nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—Skin exfoliation—Tamoxifen—pancreatic cancer	0.0356	0.0386	CcSEcCtD
Dobutamine—Skin exfoliation—Erlotinib—pancreatic cancer	0.0352	0.0382	CcSEcCtD
Dobutamine—Skin necrosis—Epirubicin—pancreatic cancer	0.0351	0.0381	CcSEcCtD
Dobutamine—Skin necrosis—Doxorubicin—pancreatic cancer	0.0325	0.0353	CcSEcCtD
Dobutamine—Skin exfoliation—Sunitinib—pancreatic cancer	0.0305	0.0331	CcSEcCtD
Dobutamine—Skin exfoliation—Gemcitabine—pancreatic cancer	0.0245	0.0266	CcSEcCtD
Dobutamine—Hypokalaemia—Erlotinib—pancreatic cancer	0.0244	0.0265	CcSEcCtD
Dobutamine—Angina pectoris—Tamoxifen—pancreatic cancer	0.0228	0.0247	CcSEcCtD
Dobutamine—Hypokalaemia—Sunitinib—pancreatic cancer	0.0211	0.0229	CcSEcCtD
Dobutamine—Hypokalaemia—Irinotecan—pancreatic cancer	0.0174	0.0189	CcSEcCtD
Dobutamine—Skin exfoliation—Docetaxel—pancreatic cancer	0.0174	0.0188	CcSEcCtD
Dobutamine—Hypokalaemia—Gemcitabine—pancreatic cancer	0.0169	0.0184	CcSEcCtD
Dobutamine—Angina pectoris—Irinotecan—pancreatic cancer	0.0161	0.0175	CcSEcCtD
Dobutamine—Angina pectoris—Fluorouracil—pancreatic cancer	0.0154	0.0167	CcSEcCtD
Dobutamine—Phlebitis—Docetaxel—pancreatic cancer	0.0153	0.0166	CcSEcCtD
Dobutamine—Chest pain—Tamoxifen—pancreatic cancer	0.0139	0.0151	CcSEcCtD
Dobutamine—Chest pain—Erlotinib—pancreatic cancer	0.0137	0.0149	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Epirubicin—pancreatic cancer	0.0136	0.0147	CcSEcCtD
Dobutamine—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.013	0.0141	CcSEcCtD
Dobutamine—Thrombocytopenia—Erlotinib—pancreatic cancer	0.0129	0.014	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Doxorubicin—pancreatic cancer	0.0126	0.0136	CcSEcCtD
Dobutamine—Chest pain—Sunitinib—pancreatic cancer	0.0119	0.0129	CcSEcCtD
Dobutamine—Dyspnoea—Tamoxifen—pancreatic cancer	0.0119	0.0129	CcSEcCtD
Dobutamine—Dyspnoea—Erlotinib—pancreatic cancer	0.0117	0.0127	CcSEcCtD
Dobutamine—Skin exfoliation—Epirubicin—pancreatic cancer	0.0117	0.0127	CcSEcCtD
Dobutamine—Thrombocytopenia—Sunitinib—pancreatic cancer	0.0112	0.0121	CcSEcCtD
Dobutamine—Angina pectoris—Docetaxel—pancreatic cancer	0.0111	0.0121	CcSEcCtD
Dobutamine—Skin exfoliation—Doxorubicin—pancreatic cancer	0.0108	0.0118	CcSEcCtD
Dobutamine—Phlebitis—Epirubicin—pancreatic cancer	0.0103	0.0112	CcSEcCtD
Dobutamine—Dyspnoea—Sunitinib—pancreatic cancer	0.0102	0.011	CcSEcCtD
Dobutamine—Phlebitis—Doxorubicin—pancreatic cancer	0.00957	0.0104	CcSEcCtD
Dobutamine—Chest pain—Gemcitabine—pancreatic cancer	0.00954	0.0104	CcSEcCtD
Dobutamine—Pruritus—Tamoxifen—pancreatic cancer	0.00941	0.0102	CcSEcCtD
Dobutamine—Chest pain—Fluorouracil—pancreatic cancer	0.00938	0.0102	CcSEcCtD
Dobutamine—Pruritus—Erlotinib—pancreatic cancer	0.00931	0.0101	CcSEcCtD
Dobutamine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00919	0.00998	CcSEcCtD
Dobutamine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00895	0.00972	CcSEcCtD
Dobutamine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.0088	0.00955	CcSEcCtD
Dobutamine—Tachycardia—Fluorouracil—pancreatic cancer	0.00878	0.00952	CcSEcCtD
Dobutamine—Hypotension—Irinotecan—pancreatic cancer	0.00877	0.00952	CcSEcCtD
Dobutamine—Hypotension—Gemcitabine—pancreatic cancer	0.00855	0.00927	CcSEcCtD
Dobutamine—Hypotension—Fluorouracil—pancreatic cancer	0.0084	0.00912	CcSEcCtD
Dobutamine—Dyspnoea—Irinotecan—pancreatic cancer	0.00837	0.00908	CcSEcCtD
Dobutamine—Headache—Tamoxifen—pancreatic cancer	0.00834	0.00905	CcSEcCtD
Dobutamine—Headache—Erlotinib—pancreatic cancer	0.00825	0.00895	CcSEcCtD
Dobutamine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00815	0.00885	CcSEcCtD
Dobutamine—Hypokalaemia—Epirubicin—pancreatic cancer	0.00811	0.0088	CcSEcCtD
Dobutamine—Pruritus—Sunitinib—pancreatic cancer	0.00806	0.00875	CcSEcCtD
Dobutamine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00802	0.0087	CcSEcCtD
Dobutamine—Nausea—Tamoxifen—pancreatic cancer	0.0079	0.00858	CcSEcCtD
Dobutamine—Nausea—Erlotinib—pancreatic cancer	0.00782	0.00849	CcSEcCtD
Dobutamine—Hypokalaemia—Doxorubicin—pancreatic cancer	0.0075	0.00814	CcSEcCtD
Dobutamine—Angina pectoris—Epirubicin—pancreatic cancer	0.0075	0.00814	CcSEcCtD
Dobutamine—Headache—Sunitinib—pancreatic cancer	0.00714	0.00775	CcSEcCtD
Dobutamine—Palpitations—Docetaxel—pancreatic cancer	0.00703	0.00763	CcSEcCtD
Dobutamine—Angina pectoris—Doxorubicin—pancreatic cancer	0.00694	0.00753	CcSEcCtD
Dobutamine—Chest pain—Docetaxel—pancreatic cancer	0.00677	0.00735	CcSEcCtD
Dobutamine—Nausea—Sunitinib—pancreatic cancer	0.00677	0.00735	CcSEcCtD
Dobutamine—Pruritus—Gemcitabine—pancreatic cancer	0.00647	0.00702	CcSEcCtD
Dobutamine—Pruritus—Fluorouracil—pancreatic cancer	0.00636	0.0069	CcSEcCtD
Dobutamine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00635	0.0069	CcSEcCtD
Dobutamine—Tachycardia—Docetaxel—pancreatic cancer	0.00633	0.00687	CcSEcCtD
Dobutamine—Hypotension—Docetaxel—pancreatic cancer	0.00606	0.00658	CcSEcCtD
Dobutamine—Headache—Irinotecan—pancreatic cancer	0.00588	0.00638	CcSEcCtD
Dobutamine—Dyspnoea—Docetaxel—pancreatic cancer	0.00579	0.00628	CcSEcCtD
Dobutamine—Headache—Gemcitabine—pancreatic cancer	0.00573	0.00622	CcSEcCtD
Dobutamine—Headache—Fluorouracil—pancreatic cancer	0.00563	0.00611	CcSEcCtD
Dobutamine—Nausea—Irinotecan—pancreatic cancer	0.00558	0.00605	CcSEcCtD
Dobutamine—Nausea—Gemcitabine—pancreatic cancer	0.00543	0.00589	CcSEcCtD
Dobutamine—Nausea—Fluorouracil—pancreatic cancer	0.00534	0.0058	CcSEcCtD
Dobutamine—Palpitations—Epirubicin—pancreatic cancer	0.00474	0.00514	CcSEcCtD
Dobutamine—Pruritus—Docetaxel—pancreatic cancer	0.00459	0.00498	CcSEcCtD
Dobutamine—Chest pain—Epirubicin—pancreatic cancer	0.00457	0.00496	CcSEcCtD
Dobutamine—Palpitations—Doxorubicin—pancreatic cancer	0.00439	0.00476	CcSEcCtD
Dobutamine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00429	0.00465	CcSEcCtD
Dobutamine—Tachycardia—Epirubicin—pancreatic cancer	0.00427	0.00464	CcSEcCtD
Dobutamine—Chest pain—Doxorubicin—pancreatic cancer	0.00423	0.00458	CcSEcCtD
Dobutamine—Hypotension—Epirubicin—pancreatic cancer	0.00409	0.00444	CcSEcCtD
Dobutamine—Headache—Docetaxel—pancreatic cancer	0.00407	0.00441	CcSEcCtD
Dobutamine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00397	0.0043	CcSEcCtD
Dobutamine—Tachycardia—Doxorubicin—pancreatic cancer	0.00395	0.00429	CcSEcCtD
Dobutamine—Dyspnoea—Epirubicin—pancreatic cancer	0.0039	0.00424	CcSEcCtD
Dobutamine—Nausea—Docetaxel—pancreatic cancer	0.00385	0.00418	CcSEcCtD
Dobutamine—Hypotension—Doxorubicin—pancreatic cancer	0.00378	0.00411	CcSEcCtD
Dobutamine—Dyspnoea—Doxorubicin—pancreatic cancer	0.00361	0.00392	CcSEcCtD
Dobutamine—Pruritus—Epirubicin—pancreatic cancer	0.0031	0.00336	CcSEcCtD
Dobutamine—Pruritus—Doxorubicin—pancreatic cancer	0.00287	0.00311	CcSEcCtD
Dobutamine—Headache—Epirubicin—pancreatic cancer	0.00274	0.00298	CcSEcCtD
Dobutamine—Nausea—Epirubicin—pancreatic cancer	0.0026	0.00282	CcSEcCtD
Dobutamine—Headache—Doxorubicin—pancreatic cancer	0.00254	0.00275	CcSEcCtD
Dobutamine—Nausea—Doxorubicin—pancreatic cancer	0.00241	0.00261	CcSEcCtD
Dobutamine—ADRB2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000144	0.00184	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—SCT—pancreatic cancer	0.000144	0.00183	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000142	0.00181	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—SCT—pancreatic cancer	0.000141	0.00179	CbGpPWpGaD
Dobutamine—CA2—Metabolism—STK11—pancreatic cancer	0.000139	0.00177	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRLHR—pancreatic cancer	0.000138	0.00175	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—APOE—pancreatic cancer	0.000137	0.00175	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCK—pancreatic cancer	0.000137	0.00175	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRLHR—pancreatic cancer	0.000135	0.00171	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCK—pancreatic cancer	0.000134	0.00171	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CNR2—pancreatic cancer	0.000134	0.0017	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000134	0.0017	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CG—pancreatic cancer	0.000133	0.00169	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000132	0.00168	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CNR2—pancreatic cancer	0.000131	0.00167	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000131	0.00167	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—IAPP—pancreatic cancer	0.00013	0.00166	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000129	0.00165	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000129	0.00165	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CD44—pancreatic cancer	0.000129	0.00165	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000129	0.00164	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PPARG—pancreatic cancer	0.000128	0.00163	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000128	0.00163	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ZNRF3—pancreatic cancer	0.000126	0.00161	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ACVR1B—pancreatic cancer	0.000126	0.00161	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—HRAS—pancreatic cancer	0.000126	0.00161	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000125	0.0016	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CG—pancreatic cancer	0.000124	0.00158	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GCG—pancreatic cancer	0.000124	0.00158	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000122	0.00156	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—SHH—pancreatic cancer	0.00012	0.00153	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PPARG—pancreatic cancer	0.00012	0.00152	CbGpPWpGaD
Dobutamine—CA2—Metabolism—TYMS—pancreatic cancer	0.00012	0.00152	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IAPP—pancreatic cancer	0.000118	0.00151	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—SHH—pancreatic cancer	0.000117	0.00149	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SSTR3—pancreatic cancer	0.000117	0.00149	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DTX1—pancreatic cancer	0.000117	0.00149	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CD—pancreatic cancer	0.000117	0.00149	CbGpPWpGaD
Dobutamine—COMT—Metabolism—STK11—pancreatic cancer	0.000116	0.00148	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IAPP—pancreatic cancer	0.000116	0.00148	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—SST—pancreatic cancer	0.000114	0.00146	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SSTR3—pancreatic cancer	0.000114	0.00146	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DTX1—pancreatic cancer	0.000114	0.00146	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000114	0.00145	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000114	0.00145	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SSTR1—pancreatic cancer	0.000112	0.00143	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—SST—pancreatic cancer	0.000112	0.00143	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000111	0.00142	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000111	0.00142	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PPY—pancreatic cancer	0.00011	0.0014	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	0.00011	0.0014	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CD—pancreatic cancer	0.000109	0.00139	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SSTR2—pancreatic cancer	0.000108	0.00137	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PPY—pancreatic cancer	0.000108	0.00137	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000106	0.00135	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	0.000106	0.00135	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCKBR—pancreatic cancer	0.000104	0.00133	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—SST—pancreatic cancer	0.000104	0.00132	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000104	0.00132	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000103	0.00132	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GCG—pancreatic cancer	0.000102	0.0013	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	0.000102	0.0013	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—SST—pancreatic cancer	0.000102	0.0013	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CB—pancreatic cancer	0.000102	0.0013	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000101	0.00129	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTGS2—pancreatic cancer	0.000101	0.00128	CbGpPWpGaD
Dobutamine—COMT—Metabolism—TYMS—pancreatic cancer	0.0001	0.00128	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	9.98e-05	0.00127	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DTX4—pancreatic cancer	9.8e-05	0.00125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GLI1—pancreatic cancer	9.8e-05	0.00125	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AGTR1—pancreatic cancer	9.73e-05	0.00124	CbGpPWpGaD
Dobutamine—CA2—Metabolism—APOE—pancreatic cancer	9.72e-05	0.00124	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	9.6e-05	0.00122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	9.58e-05	0.00122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	9.58e-05	0.00122	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	9.53e-05	0.00121	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	9.53e-05	0.00121	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	9.52e-05	0.00121	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CB—pancreatic cancer	9.49e-05	0.00121	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTGS2—pancreatic cancer	9.4e-05	0.0012	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	9.39e-05	0.0012	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	9.32e-05	0.00119	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	9.32e-05	0.00119	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	9.27e-05	0.00118	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	9.17e-05	0.00117	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	9.06e-05	0.00116	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	8.97e-05	0.00114	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GAST—pancreatic cancer	8.96e-05	0.00114	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	8.84e-05	0.00113	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTEN—pancreatic cancer	8.78e-05	0.00112	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CG—pancreatic cancer	8.77e-05	0.00112	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GAST—pancreatic cancer	8.77e-05	0.00112	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	8.65e-05	0.0011	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SCT—pancreatic cancer	8.5e-05	0.00108	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	8.5e-05	0.00108	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PPARG—pancreatic cancer	8.47e-05	0.00108	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SCT—pancreatic cancer	8.31e-05	0.00106	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	8.31e-05	0.00106	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTEN—pancreatic cancer	8.2e-05	0.00105	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APOE—pancreatic cancer	8.15e-05	0.00104	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCK—pancreatic cancer	8.1e-05	0.00103	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCK—pancreatic cancer	7.93e-05	0.00101	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	7.9e-05	0.00101	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	7.9e-05	0.00101	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	7.89e-05	0.00101	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	7.77e-05	0.00099	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	7.73e-05	0.000984	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	7.73e-05	0.000984	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	7.72e-05	0.000984	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CD—pancreatic cancer	7.71e-05	0.000983	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	7.6e-05	0.000969	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	7.53e-05	0.00096	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	7.43e-05	0.000946	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	7.37e-05	0.000939	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CG—pancreatic cancer	7.35e-05	0.000937	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	7.26e-05	0.000926	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PPARG—pancreatic cancer	7.1e-05	0.000904	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SHH—pancreatic cancer	7.08e-05	0.000903	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	7.04e-05	0.000897	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	7e-05	0.000891	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SHH—pancreatic cancer	6.93e-05	0.000883	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	6.89e-05	0.000877	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	6.84e-05	0.000872	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CB—pancreatic cancer	6.72e-05	0.000857	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	6.72e-05	0.000856	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	6.72e-05	0.000856	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS2—pancreatic cancer	6.66e-05	0.000849	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	6.57e-05	0.000837	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	6.57e-05	0.000837	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CD—pancreatic cancer	6.46e-05	0.000824	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PIK3CA—pancreatic cancer	6.2e-05	0.00079	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SST—pancreatic cancer	6.14e-05	0.000783	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.06e-05	0.000772	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	6.01e-05	0.000766	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SST—pancreatic cancer	6.01e-05	0.000766	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	5.99e-05	0.000763	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.93e-05	0.000755	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	5.88e-05	0.000749	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	5.85e-05	0.000746	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTEN—pancreatic cancer	5.81e-05	0.00074	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PIK3CA—pancreatic cancer	5.79e-05	0.000737	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	5.67e-05	0.000722	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CB—pancreatic cancer	5.63e-05	0.000718	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—pancreatic cancer	5.58e-05	0.000711	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	5.54e-05	0.000707	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	5.5e-05	0.000701	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GCG—pancreatic cancer	5.47e-05	0.000698	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	5.38e-05	0.000686	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GCG—pancreatic cancer	5.35e-05	0.000682	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.33e-05	0.000679	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	5.22e-05	0.000665	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.21e-05	0.000664	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STK11—pancreatic cancer	5.15e-05	0.000656	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	5.11e-05	0.000651	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—pancreatic cancer	5.06e-05	0.000645	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STK11—pancreatic cancer	5.03e-05	0.000642	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTEN—pancreatic cancer	4.87e-05	0.00062	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	4.84e-05	0.000616	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	4.73e-05	0.000603	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—pancreatic cancer	4.73e-05	0.000602	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.64e-05	0.000591	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.54e-05	0.000579	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	4.51e-05	0.000574	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	4.46e-05	0.000568	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	4.41e-05	0.000562	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HES1—pancreatic cancer	4.4e-05	0.000561	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	4.36e-05	0.000556	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HES1—pancreatic cancer	4.31e-05	0.000549	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	4.22e-05	0.000537	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	4.12e-05	0.000525	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PIK3CA—pancreatic cancer	4.1e-05	0.000522	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	4.05e-05	0.000516	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	3.96e-05	0.000505	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TERT—pancreatic cancer	3.86e-05	0.000491	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TERT—pancreatic cancer	3.77e-05	0.000481	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	3.69e-05	0.00047	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	3.68e-05	0.000469	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	3.61e-05	0.00046	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOE—pancreatic cancer	3.6e-05	0.000459	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	3.6e-05	0.000459	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KDR—pancreatic cancer	3.53e-05	0.00045	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOE—pancreatic cancer	3.52e-05	0.000449	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KDR—pancreatic cancer	3.45e-05	0.00044	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PIK3CA—pancreatic cancer	3.43e-05	0.000438	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	3.36e-05	0.000428	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—pancreatic cancer	3.35e-05	0.000427	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	3.32e-05	0.000423	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	3.28e-05	0.000418	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	3.25e-05	0.000414	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	3.25e-05	0.000414	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	3.25e-05	0.000414	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGF—pancreatic cancer	3.21e-05	0.000409	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	3.18e-05	0.000405	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	3.18e-05	0.000405	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGF—pancreatic cancer	3.14e-05	0.0004	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	2.96e-05	0.000377	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	2.9e-05	0.000369	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	2.86e-05	0.000364	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.83e-05	0.000361	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—pancreatic cancer	2.81e-05	0.000357	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	2.8e-05	0.000356	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	2.79e-05	0.000356	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.77e-05	0.000353	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	2.74e-05	0.000349	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.57e-05	0.000327	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.51e-05	0.00032	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	2.49e-05	0.000317	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	2.44e-05	0.00031	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	2.39e-05	0.000305	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	2.38e-05	0.000303	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	2.34e-05	0.000298	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	2.33e-05	0.000296	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	2.31e-05	0.000295	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	2.29e-05	0.000292	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	2.26e-05	0.000288	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	2.24e-05	0.000285	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	2.23e-05	0.000284	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	2.21e-05	0.000281	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	2.18e-05	0.000278	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	2.16e-05	0.000276	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	2.16e-05	0.000275	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	2.15e-05	0.000274	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	2.12e-05	0.00027	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	2.1e-05	0.000268	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	2.1e-05	0.000267	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	2.05e-05	0.000262	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SRC—pancreatic cancer	2e-05	0.000254	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SRC—pancreatic cancer	1.95e-05	0.000249	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	1.94e-05	0.000248	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	1.92e-05	0.000245	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	1.92e-05	0.000245	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	1.9e-05	0.000242	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	1.88e-05	0.00024	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	1.88e-05	0.000239	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MYC—pancreatic cancer	1.79e-05	0.000228	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	1.78e-05	0.000227	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MYC—pancreatic cancer	1.75e-05	0.000223	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	1.75e-05	0.000223	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	1.74e-05	0.000222	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	1.71e-05	0.000218	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	1.65e-05	0.000211	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	1.62e-05	0.000206	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	1.52e-05	0.000193	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	1.48e-05	0.000189	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TP53—pancreatic cancer	1.47e-05	0.000187	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TP53—pancreatic cancer	1.44e-05	0.000183	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	1.4e-05	0.000179	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	1.37e-05	0.000175	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	1.24e-05	0.000158	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	1.21e-05	0.000155	CbGpPWpGaD
